APA (7th ed.) Citation

K, A., TH, H., TT, N., S, K., O, L., LR, B., . . . HT, M. (2025). Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study. Journal of immunology (Baltimore, Md. : 1950), 214(12), 3310. https://doi.org/10.1093/jimmun/vkaf263

Chicago Style (17th ed.) Citation

K, Abe, et al. "Evaluating COVID-19 Severity Prediction and Immune Dynamics with NULISAseq: Insights from the IMPACC Study." Journal of Immunology (Baltimore, Md. : 1950) 214, no. 12 (2025): 3310. https://doi.org/10.1093/jimmun/vkaf263.

MLA (9th ed.) Citation

K, Abe, et al. "Evaluating COVID-19 Severity Prediction and Immune Dynamics with NULISAseq: Insights from the IMPACC Study." Journal of Immunology (Baltimore, Md. : 1950), vol. 214, no. 12, 2025, p. 3310, https://doi.org/10.1093/jimmun/vkaf263.